Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Siemens launches new assay for STI detection

Siemens launches new assay for STI detection

5th May 2010

Siemens has launched a new DNA-based assay which is designed to allow clinicians to detect certain common sexually-transmitted infections (STIs).

The Versant CT/GC DNA 1.0 kPCR assay utilises in vitro nucleic acid amplification to detect genetic information associated with chlamydia trachomatis and neisseria gonorrhoeae.

This allows the two conditions to be diagnosed using urine specimens, female endocervical swabs or male urethral swabs, making it a non-invasive and sensitive means of testing.

Siemens has identified this new assay technology as a measure that will aid in the fight against a health issue which affects an estimated 340 million new patients each year.

Hanjoon Ryu, senior vice-president, point of care and molecular at Siemens Healthcare Diagnostics, said: “Adding the CT/GC assay to our Versant kPCR Molecular System delivers on our commitment to offer clinical laboratories a comprehensive range of testing for key disease states, including infectious disease.”

Last month, the company won approval from the International Federation for Clinical Chemistry for its DCA Vantage diabetes analyser device to provide dual reporting functions.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.